Correlation Between DXC Technology and Emergent Biosolutions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DXC Technology and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DXC Technology and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DXC Technology Co and Emergent Biosolutions, you can compare the effects of market volatilities on DXC Technology and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DXC Technology with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of DXC Technology and Emergent Biosolutions.

Diversification Opportunities for DXC Technology and Emergent Biosolutions

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between DXC and Emergent is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding DXC Technology Co and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and DXC Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DXC Technology Co are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of DXC Technology i.e., DXC Technology and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between DXC Technology and Emergent Biosolutions

Assuming the 90 days trading horizon DXC Technology Co is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, DXC Technology Co is 2.83 times less risky than Emergent Biosolutions. The stock trades about -0.32 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  892.00  in Emergent Biosolutions on October 9, 2024 and sell it today you would earn a total of  130.00  from holding Emergent Biosolutions or generate 14.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy94.74%
ValuesDaily Returns

DXC Technology Co  vs.  Emergent Biosolutions

 Performance 
       Timeline  
DXC Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DXC Technology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, DXC Technology is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Emergent Biosolutions 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

DXC Technology and Emergent Biosolutions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DXC Technology and Emergent Biosolutions

The main advantage of trading using opposite DXC Technology and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DXC Technology position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.
The idea behind DXC Technology Co and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stocks Directory
Find actively traded stocks across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format